Suppr超能文献

甲状腺癌颅转移患者的预后和影响因素:4683 例患者的回顾性队列研究。

Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.

机构信息

Department of Surgery, Chang Gung Memorial Hospital Linkou Branch, Chang Gung University, No. 5, Fuxing St, Guishan Dist, Taoyuan City 333, Taiwan.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital Linkou Branch, Chang Gung University, No. 5, Fuxing St, Guishan Dist, Taoyuan City 333, Taiwan.

出版信息

Int J Surg. 2018 Jul;55:182-187. doi: 10.1016/j.ijsu.2018.06.001. Epub 2018 Jun 5.

Abstract

BACKGROUND

Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors.

MATERIALS AND METHODS

Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival.

RESULTS

Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome.

CONCLUSIONS

Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.

摘要

背景

甲状腺癌颅转移较为罕见。本研究旨在分析甲状腺癌颅转移患者的临床特征、治疗方法和预后,并确定相关的预后因素。

材料与方法

1977 年 1 月至 2017 年 8 月期间,共有 4683 例患者经组织学证实患有甲状腺癌,其中 25 例(0.53%)为颅转移患者,回顾其病历资料。采用 Kaplan-Meier 法和对数秩检验,以癌症特异性生存率为主要结局指标。采用 Cox 回归分析评估影响患者生存的潜在预后因素。

结果

25 例患者中,21 例为女性,4 例为男性。颅转移诊断时的中位年龄为 63 岁。16 例患者存在脑转移,9 例患者仅存在颅骨转移。甲状腺乳头状癌和滤泡状癌占 84.0%。颅转移诊断时,24 例(96.0%)患者存在颅外转移。20 例患者接受了手术治疗,4 例患者接受了姑息性放疗,1 例患者仅接受了支持治疗。颅转移诊断后的中位癌症特异性生存率为 27 个月。Kaplan-Meier 检验显示,转移部位、组织学类型和手术切除是影响生存的 3 个重要因素。Cox 回归分析显示,颅骨转移(HR:0.274,95%CI:0.083-0.904,p=0.033)和手术切除(HR:0.134,95%CI:0.019-0.929,p=0.042)是改善预后的独立预后因素。

结论

手术切除是甲状腺癌颅转移患者的主要治疗方法,仅颅骨转移与较好的预后相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验